Search

Your search keyword '"Goffin, K."' showing total 249 results

Search Constraints

Start Over You searched for: Author "Goffin, K." Remove constraint Author: "Goffin, K."
249 results on '"Goffin, K."'

Search Results

1. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

2. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

3. Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

4. Can we use immunohistochemistry as predicting factor of successful treatment with intensified neoadjuvant treatment in high-risk prostate cancer: A subanalysis of the ARNEO trial

5. Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer

8. How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.

9. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

10. Impact of renal impairment on atrial fibrillation

12. A multicentre clinical trial evaluating the safety and performance of a drop-in gamma probe for sentinel lymph node dissection in prostate cancer

14. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

15. Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort study

16. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

17. Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study

18. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation:a report from ESC-EHRA EORP-AF Long-Term General Registry

19. Sepsis at ICU admission does not decrease 30-day survival in very old patients : a post-hoc analysis of the VIP1 multinational cohort study

21. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

22. Cumulative Prognostic Score Predicting Mortality in Patients Older Than 80 Years Admitted to the ICU

23. Cumulative Prognostic Score Predicting Mortality in Patients Older Than 80 Years Admitted to the ICU

24. Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort study

26. Interim results from a multicentre clinical trial evaluating a drop-in gamma probe for sentinel lymph node dissection in prostate cancer

27. Optimal (68)Ga-PSMA and (18)F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer

28. Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

29. Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit (Intensive Care Medicine, (2018), 44, 7, (1027-1038), 10.1007/s00134-018-5196-7)

31. Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit (Intensive Care Medicine, (2018), 44, 7, (1027-1038), 10.1007/s00134-018-5196-7)

32. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit

35. 68Ga-PSMA-11-PET, 18F-PSMA-1007-PET and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Inter-tracer Variability

37. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit

38. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years)

39. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

42. Mapping of site-specific relapse in patients with biochemical recurrence following radical prostatectomy assessed by 68Ga-PSMA-11 or 11C-Choline PET/CT: Impact of postoperative androgen deprivation therapy and radiotherapy

43. Diagnostic value of FDG-positron emission tomography (PET/CT) for lymph node staging in patients with upper tract urothelial carcinoma (UTUC)

44. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Catalog

Books, media, physical & digital resources